JAMAVerified account

Analysis illustrates a need for additional mental health resources, both to prevent boarding and to support youths during boarding at acute care hospitalshttps://ja.ma/3FqKkxU 

Study found that, among patients with STEMI, a concomitant diagnosis of #COVID19 was associated with significantly higher rates of in-hospital mortalityhttps://ja.ma/3wYNOoj 

45 million health care professionals joined the @WHO urging governments and policy makers to halt or reverse climate change https://ja.ma/30v2ejH  #COP26

The @US_FDA warns clinicians and consumers not to use needle-free dermal fillers meant for different cosmetic applications. The devices can cause serious injuries including permanent damage to the lips, skin, or eyeshttps://ja.ma/31XoFik 

Thousands of US children and teens who have lost a parent or caregiver to #COVID19 face unique challenges as they grievehttps://ja.ma/3wTfMlr 

Study found prior #SARSCoV2 infection was associated with lower risk for breakthrough infection among persons receiving the SARS-CoV-2 mRNA vaccines; however, the observational study design precludes direct comparison of infection risk btwn the 2 vaccineshttps://ja.ma/3wZLmOw 

#Watch: A new JAMA video published to @YouTube discusses why #obesity may best be thought of as a chronic condition and the role of #medication to help people lose weight, including semaglutide, recently approved by the @US_FDA. #WeightLoss @drardhttps://ja.ma/wldyt 

By 2030, this global coalition led by @WHO, hopes to save 200,000 lives annually with the first strategic plan to address #meningitis around the worldhttps://ja.ma/3kE1obB 

FYI: A new JAMA video published to @YouTube discusses why #obesity may best be thought of as a chronic condition and the role of #medication to help people lose weight, including semaglutide, recently approved by the @US_FDA. #WeightLoss @drardhttps://ja.ma/wldyt 

For millions of people with a compromised immune system, 3 #COVID19 vaccine doses might not be enough. They’re still sheltering in place, waiting to see if the FDA will authorize monoclonal antibodies as prophylaxis before they're exposed to #SARSCoV2https://ja.ma/3CqB230 

#ICYMI: A new JAMA video published to @YouTube discusses why #obesity may best be thought of as a chronic condition and the role of #medication to help people lose weight, including semaglutide, recently approved by the @US_FDA. #WeightLoss @drardhttps://ja.ma/wldyt 

Listen to an Editor's Summary of the November 16 issue of JAMA by Deputy Editor Gregory Curfman, MDhttps://ja.ma/3DmNuCn 

Study found treatment w sacubitril/valsartan vs standard treatment w enalapril, valsartan, or placebo resulted in a statistically significant reduction in plasma NT-proBNP levels at 12 wk but no significant change in the 6-minute walking distance at 24 wkhttps://ja.ma/3nkSJg7 

A new JAMA video published to @YouTube discusses why #obesity may best be thought of as a chronic condition and the role of #medication to help people lose weight, including semaglutide, recently approved by the @US_FDA. #WeightLoss @drardhttps://ja.ma/wldyt 

In a new JAMA video, learn why #obesity may best be thought of as a chronic condition and the role of medication, including #semaglutide, to help people lose weighthttps://ja.ma/30ysLNF 

The @ABMSCert’s leave mandate and resultant board policy updates are important steps forward but also demonstrate the need for continued attention, evaluation, and innovationhttps://ja.ma/3C4w8s9 

Study found #COVID19 incidence and standardized mortality rates remained consistently higher among the prison population than the overall US population in the first year of the pandemichttps://ja.ma/3ogxXgK 

Study found, among patients with nonalcoholic steatohepatitis and obesity, bariatric surgery, vs nonsurgical management, was associated with a significantly lower risk of incident major adverse liver outcomes and major adverse cardiovascular eventshttps://ja.ma/3wC7bmR